$4.49 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 106 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 32.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $521,565,816 | -12.4% | 19,991,024 | 0.0% | 11.63% | -5.6% | ||
| GLAUKOS CORPnote 2.750% 6/1 | $336,238,478 | +7.5% | 271,752,000 | 0.0% | 7.50% | +15.8% | ||
| NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $176,599,951 | -2.3% | 1,744,714 | +15.3% | 3.94% | +5.3% |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $171,687,541 | +56.9% | 10,355,099 | +76.0% | 3.83% | +68.9% |
| Buy | NATERA INCnote 2.250% 5/0 | $164,112,922 | +51.9% | 101,042,000 | +19.0% | 3.66% | +63.6% | |
| VTRS | Buy | VIATRIS INC | $162,924,291 | +46.4% | 16,935,997 | +69.4% | 3.63% | +57.6% |
| AHCO | Buy | ADAPTHEALTH CORP | $131,694,781 | -10.2% | 10,594,914 | +38.9% | 2.94% | -3.2% |
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $117,283,260 | +2.3% | 144,516,000 | 0.0% | 2.62% | +10.2% | ||
| IONIS PHARMACEUTICALS INCnote 4/0 | $116,871,183 | -1.2% | 127,800,000 | 0.0% | 2.60% | +6.3% | ||
| AMED | Buy | AMEDISYS INC | $109,087,815 | +14.9% | 1,483,179 | +30.6% | 2.43% | +23.8% |
| BROOKDALE SR LIVING INCnote 2.000%10/1 | $104,789,706 | -6.6% | 145,955,000 | 0.0% | 2.34% | +0.5% | ||
| INTERCEPT PHARMACEUTICALS INnote 3.500% 2/1 | $101,202,725 | +6.3% | 98,354,000 | 0.0% | 2.26% | +14.5% | ||
| Buy | ACCOLADE INCnote 0.500% 4/0 | $96,642,410 | +31.8% | 122,598,000 | +16.8% | 2.15% | +42.0% | |
| Sell | APELLIS PHARMACEUTICALS INCnote 3.500% 9/1 | $95,989,624 | +20.8% | 51,793,000 | -0.2% | 2.14% | +30.2% | |
| Buy | INSMED INCnote 1.750% 1/1 | $94,378,258 | -1.5% | 103,200,000 | +0.5% | 2.10% | +6.1% | |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $80,627,957 | +109.4% | 5,218,638 | +122.1% | 1.80% | +125.5% |
| LRMR | LARIMAR THERAPEUTICS INC | $76,744,347 | +9.7% | 16,941,357 | 0.0% | 1.71% | +18.2% | |
| PACIRA BIOSCIENCES INCnote 0.750% 8/0 | $75,026,712 | +2.0% | 81,600,000 | 0.0% | 1.67% | +9.8% | ||
| SBTX | ARS PHARMACEUTICALS INC | $72,117,305 | -23.7% | 11,077,927 | 0.0% | 1.61% | -17.8% | |
| CNC | Buy | CENTENE CORP DEL | $67,950,750 | +46.6% | 1,075,000 | +90.3% | 1.52% | +58.0% |
| SILK | Buy | SILK RD MED INC | $67,524,293 | -8.5% | 1,725,640 | +23.6% | 1.50% | -1.5% |
| GUARDANT HEALTH INCnote 11/1 | $59,608,534 | +6.9% | 89,036,000 | 0.0% | 1.33% | +15.1% | ||
| Sell | AMYLYX PHARMACEUTICALS INC | $58,220,330 | -41.5% | 1,984,333 | -26.3% | 1.30% | -37.0% | |
| NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $58,045,159 | +2.3% | 70,204,000 | 0.0% | 1.29% | +10.1% | ||
| INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $57,036,596 | +1.1% | 57,791,000 | 0.0% | 1.27% | +8.9% | ||
| OMI | Buy | OWENS & MINOR INC NEW | $56,271,470 | +144.4% | 3,867,455 | +228.0% | 1.25% | +162.9% |
| MIRM | MIRUM PHARMACEUTICALS INC | $48,816,687 | +23.2% | 2,032,335 | 0.0% | 1.09% | +32.7% | |
| BKD | Buy | BROOKDALE SR LIVING INC | $48,397,839 | +39.8% | 16,406,047 | +29.4% | 1.08% | +50.5% |
| Buy | ENHABIT INC | $47,276,557 | +19.9% | 3,398,746 | +13.4% | 1.05% | +29.2% | |
| Buy | HILLEVAX INC | $46,840,896 | +3.9% | 2,833,690 | +5.2% | 1.04% | +11.9% | |
| LIVONGO HEALTH INCnote 0.875% 6/0 | $44,427,400 | +1.5% | 50,000,000 | 0.0% | 0.99% | +9.3% | ||
| MRUS | MERUS N V | $43,800,059 | +18.9% | 2,380,438 | 0.0% | 0.98% | +28.1% | |
| CMAX | CAREMAX INC | $42,349,110 | -26.8% | 15,861,090 | 0.0% | 0.94% | -21.2% | |
| SWTX | Buy | SPRINGWORKS THERAPEUTICS INC | $40,652,443 | +51.3% | 1,579,349 | +52.9% | 0.91% | +62.9% |
| ITCI | New | INTRA-CELLULAR THERAPIES INC | $39,746,100 | – | 734,000 | +100.0% | 0.89% | – |
| ISEE | Sell | IVERIC BIO INC | $36,606,383 | -50.1% | 1,504,578 | -56.1% | 0.82% | -46.2% |
| PTC THERAPEUTICS INCnote 1.500% 9/1 | $36,310,720 | +15.8% | 32,000,000 | 0.0% | 0.81% | +24.7% | ||
| Buy | NEWAMSTERDAM PHARMA COMPANYordinary shares | $33,623,687 | +24.4% | 2,535,723 | +2.2% | 0.75% | +33.9% | |
| COGT | COGENT BIOSCIENCES INC | $32,006,863 | -6.7% | 2,966,345 | 0.0% | 0.71% | +0.6% | |
| EOLS | Buy | EVOLUS INC | $30,193,740 | +21.1% | 3,569,000 | +7.5% | 0.67% | +30.4% |
| KURA | KURA ONCOLOGY INC | $29,144,090 | -1.5% | 2,383,000 | 0.0% | 0.65% | +6.2% | |
| HEALTH CATALYST INCnote 2.500% 4/1 | $27,186,090 | +4.5% | 30,000,000 | 0.0% | 0.61% | +12.4% | ||
| LUNG | New | PULMONX CORP | $26,862,231 | – | 2,402,704 | +100.0% | 0.60% | – |
| New | DOCGO INC | $26,460,350 | – | 3,059,000 | +100.0% | 0.59% | – | |
| EWTX | EDGEWISE THERAPEUTICS INC | $26,234,024 | -25.4% | 3,933,137 | 0.0% | 0.58% | -19.6% | |
| BLU | BELLUS HEALTH INC NEW | $25,783,200 | -12.4% | 3,581,000 | 0.0% | 0.58% | -5.6% | |
| KRYS | Buy | KRYSTAL BIOTECH INC | $24,974,637 | +80.1% | 311,949 | +78.3% | 0.56% | +94.1% |
| TERN | Sell | TERNS PHARMACEUTICALS INC | $24,383,545 | -16.0% | 2,059,421 | -27.8% | 0.54% | -9.5% |
| IDYA | IDEAYA BIOSCIENCES INC | $23,940,012 | -24.4% | 1,743,628 | 0.0% | 0.53% | -18.6% | |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $23,060,100 | – | 2,765,000 | +100.0% | 0.51% | – |
| Buy | GENEDX HOLDINGS CORP | $20,875,117 | +687.4% | 57,192,101 | +469.1% | 0.46% | +745.5% | |
| New | VENTYX BIOSCIENCES INC | $20,669,500 | – | 617,000 | +100.0% | 0.46% | – | |
| VIGIL NEUROSCIENCE INC | $20,089,178 | -21.7% | 2,052,010 | 0.0% | 0.45% | -15.6% | ||
| VKTX | New | VIKING THERAPEUTICS INC | $18,731,250 | – | 1,125,000 | +100.0% | 0.42% | – |
| GH | New | GUARDANT HEALTH INC | $18,259,737 | – | 778,999 | +100.0% | 0.41% | – |
| RVMD | Sell | REVOLUTION MEDICINES INC | $17,972,103 | -15.4% | 829,737 | -6.9% | 0.40% | -8.9% |
| XERIS BIOPHARMA HOLDINGS INCnote 5.000% 7/1 | $17,348,832 | +1.5% | 18,000,000 | 0.0% | 0.39% | +9.3% | ||
| ATEC | ALPHATEC HLDGS INC | $16,329,940 | +26.3% | 1,046,791 | 0.0% | 0.36% | +35.8% | |
| DA32 LIFE SCNCE TEC ACQSTN C | $16,192,000 | +1.3% | 1,600,000 | 0.0% | 0.36% | +9.1% | ||
| Sell | OAK STR HEALTH INCnote 3/1 | $15,185,063 | -80.0% | 15,403,000 | -84.6% | 0.34% | -78.4% | |
| TARS | Sell | TARSUS PHARMACEUTICALS INC | $14,531,322 | -25.1% | 1,156,032 | -12.7% | 0.32% | -19.4% |
| Sell | INVITAE CORPnote 2.000% 9/0 | $14,146,090 | -92.6% | 15,711,000 | -93.5% | 0.32% | -92.0% | |
| DNLI | Sell | DENALI THERAPEUTICS INC | $13,708,547 | -38.4% | 594,989 | -25.6% | 0.31% | -33.6% |
| ANAB | Sell | ANAPTYSBIO INC | $13,338,880 | -63.0% | 613,000 | -47.2% | 0.30% | -60.1% |
| New | ROIVANT SCIENCES LTD | $12,915,000 | – | 1,750,000 | +100.0% | 0.29% | – | |
| NVTA | New | INVITAE CORP | $12,520,854 | – | 9,274,707 | +100.0% | 0.28% | – |
| New | MINERALYS THERAPEUTICS INC | $11,416,469 | – | 729,021 | +100.0% | 0.26% | – | |
| INSM | Sell | INSMED INC | $11,228,209 | -15.4% | 658,546 | -0.8% | 0.25% | -9.1% |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $11,191,119 | – | 1,831,607 | +100.0% | 0.25% | – |
| PCVX | Sell | VAXCYTE INC | $11,056,600 | -67.1% | 295,000 | -57.9% | 0.25% | -64.6% |
| PRIME MEDICINE INC | $10,889,362 | -33.8% | 885,314 | 0.0% | 0.24% | -28.5% | ||
| FUSN | New | FUSION PHARMACEUTICALS INC | $10,642,710 | – | 2,823,000 | +100.0% | 0.24% | – |
| VERA | New | VERA THERAPEUTICS INCcl a | $10,088,000 | – | 1,300,000 | +100.0% | 0.22% | – |
| NUVB | NUVATION BIO INC | $9,719,068 | -13.5% | 5,854,860 | 0.0% | 0.22% | -6.9% | |
| New | STRUCTURE THERAPEUTICS INCsponsored ads | $8,921,250 | – | 375,000 | +100.0% | 0.20% | – | |
| OMIC | SINGULAR GENOMICS SYSTEMS IN | $7,805,554 | -39.8% | 6,450,871 | 0.0% | 0.17% | -35.1% | |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $7,527,000 | – | 650,000 | +100.0% | 0.17% | – |
| BLUE | New | BLUEBIRD BIO INC | $6,916,500 | – | 2,175,000 | +100.0% | 0.15% | – |
| ALEC | ALECTOR INC | $6,531,638 | -32.9% | 1,055,192 | 0.0% | 0.15% | -27.7% | |
| CSTL | CASTLE BIOSCIENCES INC | $6,182,907 | -3.5% | 272,135 | 0.0% | 0.14% | +3.8% | |
| NEOGENOMICS INCnote 1.250% 5/0 | $6,035,757 | +10.3% | 6,500,000 | 0.0% | 0.14% | +19.5% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $4,820,655 | -2.8% | 777,525 | 0.0% | 0.11% | +3.9% | |
| CABA | CABALETTA BIO INC | $3,839,364 | -10.6% | 464,252 | 0.0% | 0.09% | -3.4% | |
| NYXOAH S A | $3,400,807 | +49.7% | 455,262 | 0.0% | 0.08% | +61.7% | ||
| ABEONA THERAPEUTICS INC | $2,452,173 | -8.4% | 869,565 | 0.0% | 0.06% | 0.0% | ||
| THE ONCOLOGY INSTITUTE INC | $2,277,779 | -58.9% | 3,360,052 | 0.0% | 0.05% | -55.7% | ||
| ANNX | ANNEXON INC | $2,248,065 | -25.5% | 583,913 | 0.0% | 0.05% | -19.4% | |
| AFIB | ACUTUS MED INC | $1,999,357 | -34.4% | 2,651,667 | 0.0% | 0.04% | -28.6% | |
| RAIN | Sell | RAIN ONCOLOGY INC | $1,987,415 | -91.1% | 227,393 | -91.9% | 0.04% | -90.5% |
| New | ORCHARD THERAPEUTICS PLCspon ads new | $1,697,828 | – | 316,169 | +100.0% | 0.04% | – | |
| ROIVANT SCIENCES LTD*w exp 09/30/202 | $1,459,800 | -24.8% | 1,000,000 | 0.0% | 0.03% | -17.5% | ||
| CMAXW | CAREMAX INC*w exp 06/08/202 | $323,770 | -7.7% | 672,000 | 0.0% | 0.01% | 0.0% | |
| MDVL | MEDAVAIL HOLDINGS INC | $239,777 | -4.4% | 836,626 | 0.0% | 0.01% | 0.0% | |
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $195,140 | +2.3% | 733,333 | 0.0% | 0.00% | 0.0% | |
| NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $170,728 | +111.9% | 92,787 | 0.0% | 0.00% | +100.0% | ||
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $81,375 | -40.9% | 1,250,000 | 0.0% | 0.00% | -33.3% | ||
| SOMALOGIC INC*w exp 08/31/202 | $36,000 | -25.0% | 120,000 | 0.0% | 0.00% | 0.0% | ||
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $50,000 | -40.0% | 333,333 | 0.0% | 0.00% | -50.0% | |
| EUCRU | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $10 | 0.0% | 1 | 0.0% | 0.00% | – | |
| EUCRW | EUCRATES BIOMEDICAL ACQU COR*w exp 10/23/202 | $13,500 | -27.2% | 333,333 | 0.0% | 0.00% | – | |
| New | SIENTRA INC | $15,400 | – | 10,000 | +100.0% | 0.00% | – | |
| SNRHW | SENIOR CONNECT ACQUISITN COR*w exp 12/31/202 | $19,550 | -34.9% | 500,000 | 0.0% | 0.00% | -100.0% | |
| MTACU | MEDTECH ACQUISITION CORPunit 12/18/2025 | $10 | 0.0% | 1 | 0.0% | 0.00% | – | |
| SURROZEN INC*w exp 08/01/203 | $16,667 | +81.5% | 166,666 | 0.0% | 0.00% | – | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $20,000 | -17.0% | 166,666 | 0.0% | 0.00% | – | |
| MTACW | MEDTECH ACQUISITION CORP*w exp 12/22/202 | $20,467 | -18.1% | 333,333 | 0.0% | 0.00% | -100.0% | |
| Exit | PEAK BIO INC*w exp 10/26/202 | $0 | – | -362,500 | -100.0% | -0.00% | – | |
| SIEN | Exit | SIENTRA INC | $0 | – | -2,679,950 | -100.0% | -0.01% | – |
| ONCR | Exit | ONCORUS INC | $0 | – | -2,536,186 | -100.0% | -0.01% | – |
| Exit | PEPGEN INC | $0 | – | -60,009 | -100.0% | -0.02% | – | |
| ORTX | Exit | ORCHARD THERAPEUTICS PLCspon ads | $0 | – | -3,161,707 | -100.0% | -0.02% | – |
| GRAY | Exit | GRAYBUG VISION INC | $0 | – | -5,281,713 | -100.0% | -0.06% | – |
| KZR | Exit | KEZAR LIFE SCIENCES INC | $0 | – | -1,430,000 | -100.0% | -0.21% | – |
| PCRX | Exit | PACIRA BIOSCIENCES INC | $0 | – | -292,000 | -100.0% | -0.23% | – |
| APEN | Exit | APOLLO ENDOSURGERY INC | $0 | – | -1,750,000 | -100.0% | -0.36% | – |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -964,033 | -100.0% | -0.43% | – |
| IMGN | Exit | IMMUNOGEN INC | $0 | – | -6,358,314 | -100.0% | -0.65% | – |
| Exit | 1LIFE HEALTHCARE INCnote 3.000% 6/1 | $0 | – | -40,599,000 | -100.0% | -0.81% | – | |
| Exit | ALPHATEC HLDGS INCnote 0.750% 8/0 | $0 | – | -48,050,000 | -100.0% | -0.90% | – | |
| PHR | Exit | PHREESIA INC | $0 | – | -1,366,329 | -100.0% | -0.92% | – |
| Exit | NUVASIVE INCnote 1.000% 6/0 | $0 | – | -96,966,000 | -100.0% | -1.97% | – | |
| Exit | SAREPTA THERAPEUTICS INCdbcv 1.500%11/1 | $0 | – | -88,657,000 | -100.0% | -3.42% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.